BAM
TEVA icon

Barrett Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Barrett Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,950
Closed -$64K – 409
2021
Q4 		$64K Hold
7,950
– – ﹤0.01% 361
2021
Q3 		$77K Buy
+7,950
New +$74.4K ﹤0.01% 272
2016
Q1 		– Sell
-109
Closed -$7K – 413
2015
Q4 		$7K Buy
+109
New +$6.74K ﹤0.01% 289
2013
Q3 		– Sell
-42,660
Closed -$1.67M – 345
2013
Q2 		$1.67M Buy
+42,660
New +$1.66M 0.17% 76

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Barrett Asset Management's TEVA Position: Q1 2022 in Review

Barrett Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 7,950 shares — an estimated $64K sold.

Barrett Asset Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $1.67M in Q2 2013. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • Barrett Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Barrett Asset Management sold 7,950 Teva Pharmaceuticals shares in Q1 2022, an estimated $64K.
  • Barrett Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Barrett Asset Management's Teva Pharmaceuticals position peaked at $1.67M in Q2 2013.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.